发明名称 |
METHODS OF TREATING HEMATOLOGIC CANCERS |
摘要 |
A method of treating a hematologic cancer in a subject comprising administering to the subject an effective amount of a purine nucleoside phosphorylase inhibitor and, optionally an effective amount of an alkylating agent or an anti-CD20 agent, as well as related compositions and kits. |
申请公布号 |
AU2013201347(B2) |
申请公布日期 |
2014.04.17 |
申请号 |
AU20130201347 |
申请日期 |
2013.03.05 |
申请人 |
BIOCRYST PHARMACEUTICALS, INC. |
发明人 |
BANTIA, SHANTA;BREITFELD, PHILIP;BABU, YARLAGADDA S. |
分类号 |
A61K31/4184;A61K31/4745;A61K35/00;A61K39/395;A61K45/06;A61P35/02 |
主分类号 |
A61K31/4184 |
代理机构 |
|
代理人 |
|
主权项 |
|
地址 |
|